Oncology Perspective

• Surprising Results From the PALLAS Trial   Dr Kathy Miller discusses the surprising -- and disappointing -- results from the PALLAS trial, which caught many off-guard by being announced via press release after the virtual ASCO meeting.
  Medscape Oncology, July 01, 2020
• New Study Supports Treating Cancer Now   Dr David Kerr comments on a recent study that looked at one of the big unknowns when COVID-19 started: whether there is an increased risk for mortality for cancer patients undergoing chemotherapy.
  Medscape Oncology, July 01, 2020
• Progress in Targeted Therapy for Lung Cancer: New Data   Dr Mark Kris explains why he is even more hopeful when it comes to targeted therapy for lung cancer after seeing several trial results presented during this year's virtual ASCO meeting.
  Medscape Oncology, June 30, 2020
• Should ADAURA Trial Results Change Practice in NSCLC?   Dr Mark Kris says yes and explains why he thinks 3-year treatment with osimertinib should become the new standard of care for patients with EGFR mutation–positive NSCLC.
  Medscape Oncology, June 30, 2020
• Share Your Voice: Medscape Physician Assistant Career Satisfaction Report 2020 We'd like your thoughts on this inaugural report, in which PAs share what they like best and least about the job, current scope of practice, and other factors that influence how PAs feel about their careers.
  Medscape Family Medicine, June 30, 2020
• Medscape Physician Assistant Career Satisfaction Report 2020 How happy are PAs with their career choice? Do they feel that their compensation is fair for the work they do? Our survey has the answers.
  Medscape Features Slideshows, June 30, 2020
• Anatomy Factoids Do Not Create Great Physicians As he cleans out his house before a move, Vinay Prasad wonders whether medical school curricula could use a similar decluttering.
  Medscape Oncology, June 29, 2020
• EHA 2020Endothelial Injury May Play a Major Role in COVID-19-Associated Coagulopathy A new study suggests endothelial cell injury plays a major role in the pathogenesis of COVID-19-associated coagulopathy, a striking clinical feature of the illness.
  Medscape Oncology, June 29, 2020
• Cardiologists, Oncologists Desperately Need Your Help   Oncologists and cardiologists need to collaborate to optimize outcomes for patients with cancer and long-term survivors. Will a new subspecialty emerge?
  Mayo Clinic, June 29, 2020
• ASCO 2020: GI Cancer Highlights From David Kerr   Dr David Kerr discusses recent data on colorectal cancer, presented at the virtual ASCO meeting.
  Medscape Oncology, June 26, 2020
• NY Psych Residents Describe 'Tsunami' of COVID-19 Patients   Dr Jeffrey Lieberman speaks with three Columbia residents about the lessons imparted by training during a pandemic.
  Columbia University Psychiatry, June 26, 2020
• Breakthroughs in Immunotherapy From ASCO 2020   Insightful use of existing agents, new bispecific antibodies, and novel cell therapies are among the immunotherapy highlights from ASCO 2020 that are discussed by Dr Louis Weiner.
  Medscape, June 25, 2020
• Breakthroughs in HCC and Liver Cancer From ASCO 2020   Highlights in HCC and liver cancer from the ASCO 2020 virtual annual meeting include first- and second-line therapies in Chinese HCC patients, and two novel combinations in advanced disease.
  Medscape, June 25, 2020
• Colorectal Cancer Highlights from ASCO 2020   New standards of care for patients with MSI-H or MMRd metastatic colorectal cancer, and other key CRC results presented during the ASCO 2020 virtual meeting are discussed by Dr Benjamin Weinberg.
  Medscape, June 24, 2020
• Highlights in Ovarian Cancer From ASCO 2020   Dr Maurie Markman reports on key ovarian cancer presentations from ASCO 2020, including the eagerly awaited DESKTOP III trial, results of maintenance olaparib from the SOLO-2, and the PAOLA-1 study.
  Medscape, June 24, 2020
• Early Breast Cancer Highlights From ASCO 2020   Early breast cancer highlights from ASCO 2020 include refinement of adjuvant regimens in HER2+, selection of patients for chemo in ER+, and large-dose capecitabine maintenance in operable TNBC.
  Medscape, June 24, 2020
• Highlights in Non-Hodgkin Lymphoma From ASCO 2020   Highlights in non-Hodgkin lymphoma from the ASCO 2020 virtual annual meeting include new data on CAR T cells in relapsed/refractory NHL, and Bcl-2 inhibition and chemoimmunotherapy in Richter syndrome.
  Medscape, June 23, 2020
• Key Studies in Metastatic Breast Cancer From ASCO 2020   Key studies in metastatic breast cancer from ASCO 2020 focus on first-line checkpoint inhibition in TNBC; also, updated evidence that tucatinib plus chemotherapy benefits women with HER2+ disease.
  Medscape, June 23, 2020
• Caring for Cancer Patients in This New Normal   As the pandemic continues, Dr Mark Kris says that 'maintaining care is essential' for our cancer patients and offers suggestions on how to do so.
  Medscape Oncology, June 23, 2020
• Highlights in Non-Small Cell Lung Cancer From ASCO 2020   Dr Mark Kris reports on key studies in NSCLC from ASCO 2020, including the practice-changing ADAURA trial, results on an antibody-drug conjugate targeting HER2, and data on a new checkpoint inhibitor.
  Medscape, June 23, 2020